statistiche ricercatore

Continente	#
NA - Nord America	578
EU - Europa	442
AS - Asia	246
SA - Sud America	30
Continente sconosciuto - Info sul continente non disponibili	23
AF - Africa	5
OC - Oceania	1
Totale	1.325

Nazione	#
US - Stati Uniti d'America	547
RU - Federazione Russa	121
SG - Singapore	68
IE - Irlanda	65
IT - Italia	63
CN - Cina	57
DE - Germania	54
SE - Svezia	38
IN - India	31
VN - Vietnam	30
HK - Hong Kong	23
UA - Ucraina	23
FR - Francia	22
GB - Regno Unito	18
BR - Brasile	17
BD - Bangladesh	15
CA - Canada	15
FI - Finlandia	15
PL - Polonia	6
EC - Ecuador	5
TR - Turchia	5
CR - Costa Rica	4
EE - Estonia	4
ES - Italia	4
LT - Lituania	4
MX - Messico	4
VE - Venezuela	4
EU - Europa	3
AE - Emirati Arabi Uniti	2
DZ - Algeria	2
GP - Guadalupe	2
IQ - Iraq	2
IR - Iran	2
JM - Giamaica	2
PH - Filippine	2
PK - Pakistan	2
SA - Arabia Saudita	2
ZA - Sudafrica	2
AR - Argentina	1
AU - Australia	1
BJ - Benin	1
CL - Cile	1
CW - ???statistics.table.value.countryCode.CW???	1
GE - Georgia	1
GR - Grecia	1
GT - Guatemala	1
HN - Honduras	1
HR - Croazia	1
ID - Indonesia	1
JO - Giordania	1
JP - Giappone	1
KR - Corea	1
MD - Moldavia	1
NI - Nicaragua	1
NL - Olanda	1
PA - Panama	1
PT - Portogallo	1
PY - Paraguay	1
UY - Uruguay	1
Totale	1.306

Nome	#
Molecular prediction of durable remission after first line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia	165
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development	150
Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome	146
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild type chronic lymphocytic leukemia	137
MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia	129
Dark photon search in the mass range between 1.5 and 3.4 GeV/c 2	126
A Rare Case of Life-Threatening Jaundice Caused by Epstein-Barr Virus Infection and Secondary Cold Agglutinin Syndrome Successfully Treated with Rituximab	120
Study of J/ψ and ψ(3686) decay to ΛΛ¯ and Σ0Σ¯0 final states	118
Ponatinib for the treatment of Ph-like acute lymphoblastic leukemia	99
Innovative Use of Fostamatinib in Managing Refractory Immune Thrombocytopenia in an HIV ‐Positive Patient: A Case Report	68
Bispecific Monoclonal Antibodies in Diffuse Large B-Cell Lymphoma: Dawn of a New Era in Targeted Therapy	67
Totale	1.325

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	69	0	0	0	9	5	1	7	2	8	9	15	13
2022/2023	150	9	5	13	2	11	17	5	7	63	1	10	7
2023/2024	67	6	8	6	3	7	0	12	4	0	0	2	19
2024/2025	88	1	0	1	0	4	7	7	17	21	6	8	16
2025/2026	573	24	18	20	59	61	38	87	110	61	53	31	11
2026/2027	173	25	48	36	64	0	0	0	0	0	0	0	0
Totale													1.325